Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.50
Bid: 17.20
Ask: 17.98
Change: 0.00 (0.00%)
Spread: 0.78 (4.535%)
Open: 17.50
High: 0.00
Low: 0.00
Prev. Close: 17.50
NANO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Nanoco Announces Major Milestone Payment

8 May 2018 07:00

RNS Number : 3060N
Nanoco Group PLC
08 May 2018
 

 

This announcement contains inside information as defined in EU Regulation No. 596/2014 and is in accordance with the Company's obligations under Article 17 of that Regulation.

 

NANOCO GROUP PLC

("Nanoco" or the "Company")

 

Nanoco Announces Major Milestone Payment from US Partner

 

Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other nanomaterials, today announces that it will receive a £1.8 million payment from its undisclosed US-listed partner (the "Partner") after recently completing an important milestone in the Material Development and Supply Agreement announced in February 2018.

 

This milestone (the second of three) has been completed in line with the timetable set out in the agreement and reflects rapid progress being made. The total value of milestones in this programme triggered to date is £2.6 million.

 

Michael Edelman, Chief Executive of Nanoco, said:

 

"We are pleased to achieve this key milestone for our US Partner, which demonstrates Nanoco's ability to work with, and rapidly meet, our partner's needs. We remain confident in meeting our timelines to begin commercial supply and in addition, delivering on the expansion of our US partnership recently announced.

 

As previously disclosed, the Partner is funding the capital expenditure required to expand the manufacturing capabilities of Nanoco's existing Runcorn facility in order to supply the Partner with commercial volumes of product. This process is already underway, with an agreement reached in March to take over 10,000 sq. ft. of additional space in Runcorn to build a state-of-the-art production facility in order to commence commercial supply in January 2019.

 

- Ends -

 

For further information, please contact:

 

MHP Communications Tel: +44 (0) 20 3128 8570

Reg Hoare / Giles Robinson / Pete Lambie

nanoco@mhpc.com 

 

The person responsible for arranging for the release of this announcement on behalf of the Company is David Blain, Chief Financial Officer.

 

 

Notes for editors:

 

About Nanoco Group plc

Nanoco (LSE: NANO) harnesses the power of nano-technology to create a brighter, more sustainable future. Based on breakthrough science, Nanoco's proprietary manufacturing process enables the large-scale production of its cadmium-free CFQD® quantum dots for multiple applications including LCD display, lighting, healthcare, nano-materials and solar.Nanoco has non-exclusive manufacturing and marketing licensing agreements in display with The Dow Chemical Company, Merck KGaA of Germany and Wah Hong Industrial Corporation of Taiwan.Nanoco was founded in 2001 and is headquartered in Manchester, UK, with a US subsidiary, Nanoco Inc., in Concord, MA. Nanoco continues to build out a world-class, patent-protected IP portfolio generated both by its own innovation engine, as well as through acquisition. Nanoco is listed on the Main Market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocogroup.com. 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTKMGGKKRMGRZG
Date   Source Headline
15th May 20134:45 pmRNSHolding(s) in Company
14th May 20135:52 pmRNSHolding(s) in Company
9th May 201312:30 pmRNSRelocation of CEO to the US and Director Dealings
2nd May 20137:00 amRNSSigns Follow-on Agreement
29th Apr 20137:00 amRNSBoard Changes
24th Apr 20137:00 amRNSHolding(s) in Company
11th Apr 20134:46 pmRNSHolding(s) in Company
11th Apr 20137:00 amRNSHolding(s) in Company
28th Mar 20132:00 pmRNSAppointment of Joint Broker
27th Mar 20132:20 pmRNSHolding (s) in Company
18th Mar 20137:00 amRNSInterim Results
15th Feb 20132:08 pmRNSHolding(s) in Company
14th Feb 20131:00 pmRNSHolding(s) in Company
12th Feb 20139:49 amRNSHolding(s) in Company
6th Feb 20137:00 amRNSAppointment of Key Business Development Executives
29th Jan 20134:18 pmRNSHolding(s) in Company
28th Jan 20136:06 pmRNSHolding(s) in Company
24th Jan 20135:51 pmRNSHolding(s) in Company
23rd Jan 20137:00 amRNSLicensing Agreement with Dow Chemical
21st Jan 20137:00 amRNSNotification of Interim Results
11th Jan 20138:59 amRNSHolding(s) in Company
10th Jan 20131:19 pmRNSHolding(s) in Company
20th Dec 20127:00 amRNSSigns further agreement with Tokyo Electron
14th Dec 201210:25 amRNSResult of AGM
14th Dec 20127:00 amRNSAGM Statement
12th Dec 20123:37 pmRNSBlock Listing Application
4th Dec 20127:00 amRNSExercise of Options
12th Nov 20127:00 amRNSPosting of Annual Report & Accounts
23rd Oct 20127:00 amRNSGrant of Options
19th Oct 201212:43 pmRNSDirectors' Dealings and Exercise of Options
15th Oct 20127:00 amRNSPreliminary Results
5th Oct 20127:00 amRNSFollow-on Lighting Agreement
5th Sep 20127:00 amRNSNotification of Preliminary Results
20th Aug 20127:00 amRNSWins Government Grants
1st Aug 20127:00 amRNSTotal Voting Rights
31st Jul 20127:00 amRNSSigns Joint Development Agreement
27th Jul 20127:00 amRNSExercise of Options
25th Jun 20127:00 amRNSChange of Adviser
9th May 20127:00 amRNSAchieves US$2m Milestone
2nd Apr 20122:15 pmRNSTotal Voting Rights
28th Mar 20127:00 amRNSExercise of Options
26th Mar 20127:00 amRNSInterim Results
14th Feb 20127:00 amRNSSigns Joint Development Agreement
10th Feb 20128:56 amRNSHolding(s) in Company
7th Feb 20128:58 amRNSHolding(s) in Company
7th Feb 20128:55 amRNSHolding(s) in Company
31st Jan 20127:00 amRNSAchieves US$1m Milestone
25th Jan 20124:40 pmRNSSecond Price Monitoring Extn
25th Jan 20124:35 pmRNSPrice Monitoring Extension
20th Jan 20124:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.